🇺🇸 FDA

Drug profile · INN

iloperidone

FANAPTUM

approved N05AX14
US status
approved
Patents linked
6
News articles
0

Quick answer

iloperidone (FANAPTUM) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN iloperidone
Brand FANAPTUM
Route ORAL
Formulation TABLET
ATC code N05AX14
Originator Vanda Pharmaceuticals Netherlands B.V.

Related patents

Search patents →

  1. US 10987346

    Iloperidone for the treatment of schizophrenia

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10874659

    Iloperidone metabolite for use in the treatment of psychiatric disorders

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10441580

    Iloperidone for the treatment of schizophrenia

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10272076

    Methods for the administration of iloperidone

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9138432

    Methods for the administration of iloperidone

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8586610

    Methods for the administration of iloperidone

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is iloperidone?

iloperidone (FANAPTUM) is an FDA-listed pharmaceutical active ingredient. Associated with Vanda Pharmaceuticals Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for iloperidone?

FANAPTUM is a marketed brand name for iloperidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iloperidone?

iloperidone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.